La Jolla Pharmaceutical (LJPC) Misses Q3 EPS by 6c; Updates on GCS-100 Phase 2 in CKD
Go back to La Jolla Pharmaceutical (LJPC) Misses Q3 EPS by 6c; Updates on GCS-100 Phase 2 in CKD| LA JOLLA PHARMACEUT (NASDAQ: LJPC) | Delayed: 6.22 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.22 | 52 Week High | $35.95 | |||
| Open | $208.89 | 52 Week Low | $12.68 | |||
| Day High | $6.22 | P/E | N/A | |||
| Day Low | $6.22 | EPS | $-38.93 | |||
| Volume | 512,976 | |||||
